'As time goes by': Angiotensin II-mediated transactivation of the EGF receptor comes of age

Nephrology Dialysis Transplantation

Volumn 20, Issue 10, 2005, Pages 2050-2053

  Wolf, Gunter ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; SARALASIN;

ARTICLE; CHRONIC KIDNEY DISEASE; DISEASE COURSE; DISEASE MODEL; GLOMERULOSCLEROSIS; HUMAN; HYPERTENSION; IN VIVO STUDY; KIDNEY INJURY; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 27144449974     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi143     Document Type: Article

References (29)

1. Kshirsagar AV, Joy MS, Hogan SL, Falk RJ, Colindres RE. Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: A systematic overview of randomized placebo-controlled trials. Am J Kidney Dis 2000; 35: 695-707
2. 1 receptor antagonists in patients with chronic renal disease. J Am Soc Nephrol 2002; 13: 1100-1108
3. Wolf G, Ritz E. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney Int 2005; 67: 799-812
4. Wolf G, Butzmann U, Wenzel UO. The renin-angiotensin system and progression of renal disease: From hemodynamics to cell biology. Nephron Physiol 2003; 93: P3-P13
5. Wolf G, Neilson EG. Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol 1990; 259: F768-F777
6. Wolf G, Neilson EG. From converting enzyme inhibition to angiotensin II receptor blockade: New insight on angiotensin II receptor subtypes in the kidney. Exp Nephrol 1996; 4 [Suppl 1]: 8-19
7. Kip1: Role in angiotensin II-mediated hypertrophy of proximal tubular cells. J Am Soc Nephrol 2000: 11: 1387-1397
8. Harris RC. Regulation of S6 kinase activity in renal proximal tubule. Am J Physiol 1992; 263: F127-F134
9. Gorin Y, Kim NH, Feliers D, Bhandari B, Choudhury GG, Abboud HE. Angiotensin II activates Akt/protein kinase B by an arachidonic acid/ redox-dependent pathway and independent of phosphoinositide 3-kinase. FASEB J 2001; 15: 1909-1920
10. Norman J, Badie-Dezfooly B, Nord EP et al. EGF-induced mitogenesis in proximal tubular cells: Potentiation by angiotensin II. Am J Physiol 1987; 253: F299-F309
11. Wolf G, Kuncio GS, Sun MJ, Neilson EG. Expression of homeobox genes in a proximal tubular cell line derived from adult mice. Kidney Int 1991; 39: 1027-1033
12. Daub H, Weiss FU, Wallasch C, Ullrich A. Role of transactivation of the EGF receptor in signaling by G-protein-coupled receptors. Nature 1996; 379: 557-560
13. 2+/calmodulin-dependent transactivation of epidermal growth factor receptor. Circ Res 1998; 82: 1338-1348
14. Prenzel N, Zwick E, Duab H et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999; 402: 884-888
15. Uchiyama-Tanaka Y, Matsubara H, Mori Y et al. Involvement of HB-EGF and EGF receptor transactivation in TGF-β-mediated fibronectin expression in mesangial cells. Kidney Int 2002; 62: 799-808
16. Lautrette A, Li S, Alili R et al. Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: A new therapeutic approach. Nature Med 2005; 8: 867-874
17. Black RA, Rauch CT, Kozlosky CJ et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 1997; 385: 729-732
18. 2 receptors. Kidney Int 2002; 61: 1986-1995
19. Esteban V, Ruperez M, Sachez-Lopez E et al. Angiotensin IV activates the nuclear transcription factor-κB and related proinflammatory genes in vascular smooth muscle cells. Circ Res 2005; 96: 965-973
20. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implication for fibrosis. J Clin Invest 2003; 112: 1776-1784
21. Schäfer B, Marg B, Gschwind A, Ullrich A. Distinct ADAM metalloproteinases regulate G protein-coupled receptor-induced cell proliferation and survival. J Biol Chem 2004; 279: 47929-47938
22. Asakura M, Kitakaze M, Takashima S et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nature Med 2002; 8: 35-40
23. Whitesall SE, Hoff JB, Vollmer AP, D'Alecy LG. Comparison of simultaneous measurements of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods. Am J Physiol Heart Circ Physiol 2004; 286: H2408-H2415
24. Kagiyama S, Eguchi S, Frank GD, Inagami T, Zhang YC, Phillips I. Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense. Circulation 2002; 106: 909-912
25. Sharma K, Cook A, Smith M, Valancius C, Inscho EW. TGF-β impairs renal autoregulation via generation of ROS. Am J Physiol Renal Physiol 2005; 288: F1069-F1077
26. Harris RC. Potential physiologic roles for epidermal growth factor in the kidney. Am J Kidney Dis 1991, 17: 627-630
27. Perico N, Cordreanu I, Schieppati A, Remuzzi G. The future of renoprotection. Kidney Int 2005; 68 [Suppl 97]: S95-S101
28. Adamczak M, Gross ML, Krtil J et al. Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. J Am Soc Nephrol 2003; 14: 2833-2842
29. Remuzzi A, Fassi A, Bertani T, Perico N, Remuzzi G. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy. Am J Kidney Dis 1999; 34: 626-632